Answers are grounded in this paper and cite their sources.
Epithelial-myoepithelial carcinoma (EMCa) is a rare, low-grade malignant salivary gland tumor originating from minor salivary glands, and nasopharyngeal primary EMCa is extremely scarce with limited published case data. Due to its very low incidence, uniform standardized diagnosis and treatment guidelines have not been established, and its unique clinicopathological features and prognostic indicators remain poorly characterized. This study retrospectively reports two pathologically verified nasopharyngeal EMCa cases, conducts a systematic standardized retrieval of all published English case reports, and performs pooled comparative analysis to generate preliminary, hypothesis-generating diagnostic and therapeutic observations for this rare entity. Two single-center early-stage nasopharyngeal EMCa patients were retrospectively analyzed. A dedicated systematic literature search was implemented with explicit retrieval keywords and standardized inclusion/exclusion criteria to collect all comparable published cases for pooled clinical, pathological and survival analysis. Both patients were diagnosed with early-stage primary nasopharyngeal EMCa and received radical endoscopic skull base resection followed by adjuvant precision radiotherapy. Both patients achieved confirmed clinical complete response (cCR) based on RECIST 1.1 criteria. No local recurrence or distant metastasis was identified during follow-up durations of 52 months and 17 months, respectively. Pooled analysis of all seven cumulative nasopharyngeal EMCa cases (5 previously reported + our two cases) demonstrated predominant female incidence (85.7%) and a mean diagnostic age of 56.6 years. Patients receiving upfront surgical resection combined with adjuvant radiotherapy showed a numerically lower locoregional recurrence rate compared with patients treated with definitive chemoradiotherapy alone; notably, the two recurrent cases had a younger mean onset age of 42.5 years, an observational pattern requiring further validation in larger cohorts. Our case series and pooled-case analysis reveal the heterogeneous clinical features of early-stage nasopharyngeal EMCa. Younger age may represent a potential risk factor for recurrence. Surgical resection combined with adjuvant radiotherapy can achieve favorable medium-term symptom relief and sustained disease control. However, this preliminary observational finding is restricted by an extremely small sample size and exclusive enrollment of Stage I-II tumors, and all associated interpretations regarding prognostic features, diagnostic biomarkers, and adjuvant treatment selection should be regarded as hypothesis-generating rather than clinical recommendations. Large multicenter long-term follow-up cohorts are required to validate the generalizability of this combined multimodal strategy.
No takes yet. Share an insight, caveat, or question.
Gaoyin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: